Dr. Chitnis is a member of international efforts through the Guthy-Jackson Foundation to develop standardized datasets and diagnostic definitions for NMOSD (neuromyelitis optica spectrum disorders) and myelin oligodendrocyte glycoprotein associated diseases (MOGAD). She leads several projects to understand the disease course and treatment response in adults and children with these disorders. Most recently, Dr. Chitnis and her team identified immune mechanisms associated with MOGAD disease.